Halozyme Therapeutics, Inc. HALO
102.92 USD -0.71 (-0.69%)
At closeNov 9, 2026, 4:09 PM EST
101.01 -1.92 -1.86%
After hours · Nov 9, 4:09 PM ET
101.04 Day range 105.48
61.23 52-week range 134.00
- YTD
- +52.93%
- 1 year
- +50.82%
Analyst view
Consensus: buy
Buy
Price target (mean) 119.44 +16.1% upside
Now 102.92
- Target (low)
- 79.00
- Target (mean)
- 119.44
- Target (high)
- 149.00
Ratings (0m) 9 6 buy · 3 hold · 0 sell
- Strong buy2
- Buy4
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.63 | 2.48 – 2.78 | -0.24 | +1194.7% | 551.49M | +22.1% | 6 |
| Next quarter | 2.34 | 2.32 – 2.35 | 1.60 | +46.0% | 488.72M | +29.7% | 3 |
| Current year | 8.88 | 8.73 – 9.04 | 4.15 | +113.9% | 1.90B | +35.8% | 6 |
| Next year | 10.60 | 9.60 – 11.48 | 8.88 | +19.4% | 2.17B | +14.4% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Nov 6, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Nov 6, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 3, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 8, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 7, 2026 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Aug 7, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 7, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 7, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 7, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 21, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 29, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 19, 2026 | Benchmark | Maintained | Buy | Buy |
| Feb 19, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 8, 2026 | TD Cowen | Maintained | Buy | Buy |
| Dec 19, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 28, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 18, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Nov 4, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Oct 27, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 20, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 15, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 14, 2025 | Leerink Partners | Upgrade | Underperform | Market Perform |
| Oct 2, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 24, 2025 | Benchmark | Maintained | Buy | Buy |
